RECRUITINGOBSERVATIONAL
Registry Study of Proton Radiotherapy in Lymphoma
Multicenter Registry Study on Proton Radiotherapy for Mediastinal Lymphomas
About This Trial
The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.
Who May Be Eligible (Plain English)
Who May Qualify:
diagnosed by tissue sample (biopsy-confirmed) lymphoma according to WHO
- Patient consent
- Patient age ≥18 years.
- Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).
- Ability of the patient to give consent
Who Should NOT Join This Trial:
Age \<18 years
- Non-consent of the patient to the disclosure of his data
- Cancellation of the patient's participation in the study
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
Histologically confirmed lymphoma according to WHO
* Patient consent
* Patient age ≥18 years.
* Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).
* Ability of the patient to give consent
Exclusion Criteria:
Age \<18 years
* Non-consent of the patient to the disclosure of his data
* Cancellation of the patient's participation in the study
Treatments Being Tested
OTHER
Assesment of Effectiveness and side effects
Case Report forms, Quality of life questionaire
Locations (1)
University Hospital Heidelberg
Heidelberg, Germany